KCT0003081已完成未知
A human study for evaluating effectiveness and safety of GF bacillus enzyme SOD on antioxidant capacity
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 30(Year) 至 64(Year)（—）
- 性别
- All
入选标准
- •1) Subject who voluntarily agree to participate and signs informed consent form
- •2) Age more than 30 year old and less than 65 years old (Ratio of men and women 1:1)
- •3) Less than 36 of Recommended Foods Score
- •4) Subject who comply more than one thing of the following categories
- •-150mg/dL =Blood triglycerides< 200 mg/dL
- •-200mg/dL =Blood total cholesterol< 240 mg/dL
- •-130mg/dL =Blood LDL-cholesterol< 160 mg/d
排除标准
- •1) Impossible to performa treadmill activity
- •2) Continuous intensive workout (more than 7 hours a week) within 3 months from the first visit
- •3) Chronic smoker (= 10 cigarettes / day)
- •4) Intake more than 420 g of pure alcohol a week (Soju 7bottles/week, 1bottle/day) or an alcoholic
- •5) BMI<23 or BMI=30
- •6) Controlling body weight or have changed of body weight more than 4kg within 4 weeks before the first visit
- •7) Having difficult to consist the current workout habits or diet habits during the study
- •8) Comply the following categories
- •- Treated with hormone treatment within 6 months before the first visit
- •- Have following diseases or taking relevant medicines: thromboembolism, inflammatory disease, liver disease, kidney disease, cerebrovascular disease, cancer, uterine disease, Cardiovascular disease( hypertension, stroke etc), thyroid disease, interstinal disease, diabetes or hyperlipidemia with drug treatment
- •- A mental patient
- •- Therapeutic uses of coumadin, aspirin, or other medications that influence hemostasis within four weeks of the Screening visit. Preventive use of low-dose aspirin (e.g. 100-mg a day) is allowed.
- •9) Continuous consumption of health functional food(rasberry wine, Pycnogenol, Coenzyme Q10, meron extract, antioxidantsmultivitamin etc), prebiotics (dietary fiber, oligosaccharide etc) and probiotics (lactobacillus) within 1 months before the first visit
- •10) Donated blood within 1 month before the first visit
- •11) Known hypersensitivity to study product or any ingredient in study product
- •12) Planning to be pregnant, Pregnant or lactating women
- •13) Participation in other human study within 1 month before the first visit
- •14) Subject who has difficult to handle smartphone
- •15) Any condition that the principal investigator believes may put the subjects at under risk
研究者
相似试验
尚未招募
不适用
A human study for evaluating effectiveness and safety of GPX on gut immunityDiseases of the digestive systemKCT0005913Ewha Womens University116
已完成
不适用
A human study for evaluating effectiveness and safety of barley sprout extracts consumption on alcoholic liver damageKCT0002891Ewha Womans University76
已完成
不适用
A human study for evaluating effectiveness and safety of Theracurmin CR-033P on antioxidant capacityKCT0003322Chungnam National University80
已完成
不适用
A human study fo r evaluating effectiveness and safety o f Agastache rugo se extracts and exercise o n muscle mass and muscle functio n - Applicatio n o f research design based o n big data/artificial intelligence virtual bo dy systemKCT0006633Ewha Womens University120
已完成
不适用
A human study to evaluate the effectiveness and safety of Achyranthes and Aralia fermented by Lactobacillus Strains on joint function in subjects with knee osteoarthritisKCT0002876Semyung University Oriental Medicine Hospital70